Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Completed 6Terminated 3Withdrawn 2Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 6Thoracic 4Other hematologic neoplasm 3Gynecologic 3Genitourinary 3Dermatologic 3Lymphoid 2Tumor-Agnostic 1Sarcoma 1Other neoplasm 1Myeloid 1CNS 1

Conditions

Kidney Neoplasms 2Prostatic Neoplasms 1Castrate-Resistant Prostate Cancer 1

Interventions

Docetaxel 69pembrolizumab 48Prednisone 43Nivolumab 40enzalutamide 38Gemcitabine 37Sunitinib 36Cyclophosphamide 29Radiotherapy 26Magnetic Resonance Spectroscopy 26Leuprolide 25Abiraterone Acetate 25Sorafenib 23Everolimus 23Cisplatin 23bicalutamide 19atezolizumab 18Carboplatin 18Bevacizumab 18avelumab 17Radiosurgery 17Goserelin 17Interleukin-2 16abiraterone 15fludarabine 14Doxorubicin 14olaparib 13durvalumab 13cabozantinib 13acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Sodium Chloride × Genitourinary × Clear all
NCT03824808 2023-10-25

Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery

University of Missouri-Columbia

Phase 4 Terminated
21 enrolled 12 charts
Genitourinary

Kidney Neoplasms, Prostatic Neoplasms

NCT01083615 2016-10-12

A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Achieve Life Sciences

Phase 3 Terminated
14 enrolled
Genitourinary

Castrate-Resistant Prostate Cancer

NCT01486550 2014-10-09

VONE

Regional Hospital Holstebro

Phase 4 Terminated
14 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡